Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Evaluation of the Effects of the New Program for Cognitive Enhancement and Improvement in the Elderly
Not Applicable
Completed
- Conditions
- Aging
- Interventions
- Other: Cognitive rehabilitation program
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT03401775
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Resistance and Immune Response to Palbociclib in Breast Cancer
Not Applicable
- Conditions
- Breast Cancer Stage IV
- First Posted Date
- 2018-01-17
- Last Posted Date
- 2018-01-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03401359
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation
- First Posted Date
- 2018-01-16
- Last Posted Date
- 2018-01-16
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT03399669
- Locations
- 🇰🇷
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Bispectral Index Throughout Esophageal Cancer Operation
Not Applicable
Completed
- Conditions
- Esophageal Cancer
- Interventions
- Device: BIS
- First Posted Date
- 2018-01-12
- Last Posted Date
- 2018-09-04
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT03397745
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Brain Imaging Study of Brain Plasticity in Chronic Stroke Patients
Completed
- Conditions
- Chronic Stroke
- Interventions
- Other: Chronic stroke
- First Posted Date
- 2018-01-08
- Last Posted Date
- 2023-03-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT03392519
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Noninvasive Dual-mode Stimulation Therapy for Neurorehabilitation in Stroke
Not Applicable
Completed
- Conditions
- Stroke
- Interventions
- Device: Dual-mode stimulationDevice: Single sham stimulation
- First Posted Date
- 2018-01-04
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 43
- Registration Number
- NCT03390192
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of a Wearable Hip Assist Robot on Cardiopulmonary Metabolic Efficiency During Stair Ascent in Elderly Adults
Not Applicable
Completed
- Conditions
- Health BehaviorGait, Unsteady
- Interventions
- Device: Wearable hip assist robot
- First Posted Date
- 2018-01-03
- Last Posted Date
- 2018-01-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT03389165
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Effects of Whole-body Vibration Exercise in Brain Injury Patients With Minimally Conscious State
Not Applicable
- Conditions
- Minimally Conscious StateBrain Injuries
- Interventions
- Other: ExersiceDevice: Whole body vibration
- First Posted Date
- 2018-01-03
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT03389113
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Intravascular Imaging- Versus Angiography-Guided Percutaneous Coronary Intervention For Complex Coronary Artery Disease
Not Applicable
Completed
- Conditions
- AtherosclerosisCoronary Artery Disease
- Interventions
- Procedure: Percutaneous coronary intervention for complex lesionDevice: Drug-eluting stentDevice: Drug-coated balloonDevice: Intravascular imaging (IVUS or OCT)
- First Posted Date
- 2017-12-22
- Last Posted Date
- 2023-01-18
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1639
- Registration Number
- NCT03381872
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Definitive CCRT Combined With Durvalumab and Tremelimumab for Inoperable Esophageal Cancer
- First Posted Date
- 2017-12-19
- Last Posted Date
- 2020-12-17
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT03377400
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, MA, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath